Summary
The M protein on the surface of group A streptococci contains epitopes that evoke type-specific protective immunity against subsequent encounters with the related serotypes of streptococci. Because some of the M proteins are closely associated with potentially harmful epitopes that give rise to antibodies cross-reactive with host tissues, especially the heart, we have undertaken studies of the covalent structures of M protein polypeptide fragments extracted with pepsin at pH 5.8 from rheumatogenic strains of group A streptococci. We have identified 35-residue peptide fragments of type 24 M protein that elicit protective, but not heart-cross-reactive antibodies. Chemically synthesized copies of a 35-residue peptide and subpeptides containing as few as 13 M protein amino acid residues were shown to be immunogenic when covalently conjugated to poly-L-lysine or tetanus toxoid. A 20-residue NH2 terminal peptide of type 5 M protein was shown to be similarly immunogenic. The immune responses in each case were protective, but not tissue cross-reactive. These results show that the whole M protein molecule is not necessary for the production of protective immunity. Moreover, selected synthetic peptide copies of the natural M protein molecule provide effective immunogens without the potential fear of tissue damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stollerman GH (1975) Rheumatic fever and streptococcal infection. Grune and Stratton, New York
Kaplan MH (1963) J Immunol 90: 595–606
Lancefield RC (1962) J Immunol 89: 307–313
Beachey EH, Campbell GL, Ofek I (1972) Infect Immun 9: 891–896
Beachey EH, Stollerman GH, Chiang EY, Chiang TM, Seyer JM, Kang JM (1977) J Exp Med 145: 1479–1483
Beachey EH, Stollerman GH, Johnson RH, Ofek I, Bisno AL (1979) J Exp Med 150: 862–877
Dale JB, Beachey EH (1982) J Exp Med 156: 1165–1167
Phillips GN, Flicker PF, Cohen C, Manjula BN, Fischetti VA (1982) Proc Natl Acad Sci USA 78: 4689–4693
Fox EN, Wittner MK (1969) Immunochemistry 6: 11–24
Russel H, Facklam RR, Edwards LR (1975) Infect Immun 12: 679–686
Fischetti VA, Gotschlich EC, Siviglia G, Zabriskie JB (1976) J Exp Med 144: 32–53
Vosti KL, Williams WK (1978) Infect Immun 21: 546–555
Beachey EH, Cunningham MW (1973) Infect Immun 8: 19–24
Cunningham MW, Beachey EH (1975) J Immunol 115: 1002–1006
Beachey EH, Seyer JM, Kang AH (1978) Proc Natl Acad Sci USA 75: 3163–3167
Hasty DL, Beachey EH, Simpson WA, Dale JB (1982) J Exp Med 155: 1010–1018
Fox EN, Wittner MK (1968) J Immunol 100: 39–5
Wittner MK, Fox EN (1977) Infect Immun 15: 104–108
Fischetti VA (1977) J Exp Med 146: 1108–1123
Dale JB, Ofek I, Beachey EH (1980) J Exp Med 151: 1026–1038
Beachey EH, Seyer JM (1982) In: Robbins JB, Hill JC, Sadoff JC (eds) Bacterial vaccines. Thieme-Stratton, New York, pp 401–410
Beachey EH, Seyer JM, Kang AH (1980) J Biol Chem 255: 6284–6289
Beachey EH, Seyer JM, Dale JB, Simpson WA, Kang AH (1981) Nature 292: 457–459
Beachey EH, Seyer JM, Dale JB, Hasty DL (1983) J Biol Chem 258: 13250–13257
Manjula BN, Fischetti VA (1980) J Immunol 124: 261–267
Manjula BN, Fischetti VA (1980) J Exp Med 151: 695–707
Fischetti VA, Manjula BN (1982) In: Robbins JB, Hills JC, Sadoff JC (eds) Bacterial vaccines. Thieme-Stratton, New York, pp 411–418
Manjula BN, Acharya AS, Mische SM, Fariwell T, Fischetti VA (1984) J Biol Chem 259: 3686–3693
Hosein B, McCarty M, Fischetti VA (1979) Proc Natl Acad Sci USA 76: 3765–3768
Merrifield RB (1963) J Am Chem Soc 85: 2149–2155
Jolivet M, Audibert F, Beachey EH, Tarter A, Gras-Masse H, Chedid L (1984) Biochem Biophys Res Comm 117: 359–366
Beachey EH, Tarter A, Seyer JM, Chedid L (1984) Proc Natl Acad Sci USA 81: 2203–2207
Dale JB, Syer JM, Beachey EH (1983) J Exp Med 158: 1727–1732
Hopp TP, Wood KR (1981) Proc Natl Acad Sci USA 78: 3824–3828
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Beachey, E.H. (1985). Protective Immunogenicity of Chemically Synthesized Peptide Fragments of Group A Streptococcal M Proteins. In: Jackson, G.G., Thomas, H. (eds) The Pathogenesis of Bacterial Infections. Bayer-Symposium, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70351-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-70351-5_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70353-9
Online ISBN: 978-3-642-70351-5
eBook Packages: Springer Book Archive